Pacira BioSciences (PCRX) Interest Expenses (2010 - 2026)
Pacira BioSciences (PCRX) posted quarterly Interest Expenses of $57.3 million for Q1 2026, little changed year-over-year from $57.3 million in Q1 2025, and up 1261.69% quarter-over-quarter from $4.2 million in Q4 2025.
Pacira BioSciences (PCRX) Interest Expenses (2010 - 2026) Analysis & Trends
Pacira BioSciences' Interest Expenses history runs 17 years deep, the most recent figure standing at $57.3 million for Q1 2026.
- In Q1 2026, Interest Expenses changed 0.0% year-over-year to $57.3 million; the TTM figure through Mar 2026 stood at $57.3 million (changed 0.0% YoY), while the FY2025 annual figure was $57.3 million, up 130.9% from the prior year.
- Interest Expenses for Q1 2026 stood at $57.3 million, up from $4.2 million in the prior quarter.
- The five-year high for Interest Expenses was $60.2 million in Q2 2025, with the low at $3.4 million in Q4 2023.
- The 5-year median for Interest Expenses is $11.0 million (2022), against an average of $28.3 million.
- The sharpest annual moves came in 2023 and 2024: Interest Expenses slumped 69.1% in 2023, then surged 1550.82% in 2024.
- Pacira BioSciences' Interest Expenses stood at $11.0 million in 2022, then plunged by 69.1% to $3.4 million in 2023, then jumped by 37.16% to $4.7 million in 2024, then dropped by 10.09% to $4.2 million in 2025, then surged by 1261.69% to $57.3 million in 2026.
- Business Quant data shows PCRX's Interest Expenses at $57.3 million in Q1 2026, $4.2 million in Q4 2025, and $57.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Pacira BioSciences | 939.59 Mn | 688.56 Mn | 148.24 Mn | 3.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 58.97 Mn |
| Jun 30, 2026 | 58.97 Mn |
| Mar 31, 2026 | 57.30 Mn |
| Mar 31, 2026 | 57.30 Mn |
| Dec 31, 2025 | 4.21 Mn |
| Dec 31, 2025 | 4.21 Mn |
| Sep 30, 2025 | 57.30 Mn |
| Sep 30, 2025 | 57.30 Mn |
| Jun 30, 2025 | 60.16 Mn |
| Jun 30, 2025 | 60.16 Mn |
| Mar 31, 2025 | 57.30 Mn |
| Mar 31, 2025 | 57.30 Mn |
| Dec 31, 2024 | 4.68 Mn |
| Dec 31, 2024 | 4.68 Mn |
| Sep 30, 2024 | 57.30 Mn |
| Sep 30, 2024 | 57.30 Mn |
| Jun 30, 2024 | 57.30 Mn |
| Jun 30, 2024 | 57.30 Mn |
| Mar 31, 2024 | 57.30 Mn |
| Mar 31, 2024 | 57.30 Mn |